Table 3.
The summary change of mean larger Xie-kawashima itch scale between latter seven-day pre-observation and latter seven-day treatment period.
| Groups | LS means | 95%CI | p Value | |
|---|---|---|---|---|
| 5μg Nalfurafine VS placebo | 5μg Nalfurafine | 1.37 | (1.12, 1.61) | |
| Placebo | 1.13 | (0.77, 1.48) | ||
| 5μg Nalfurafine-placebo | 0.24 | (−0.19, 0.67) | .271 | |
| 2.5 μg Nalfurafine VS placebo | 2.5μg Nalfurafine | 1.23 | (0.99, 1.47) | |
| Placebo | 1.14 | (0.80, 1.49) | ||
| 2.5 μg Nalfurafine-placebo | 0.09 | (−0.33, 0.51) | .673 |
Abbreviations: LS means: least-squares means; CI: confidence interval.